some more news., page-2

From traders report


The main thing to note here is that this guy is the GSK asia pacific dude and is reporting on only asia pacific sales not worldwide. Ie we know the cheks and emirites for instance have bought some relenza in the last month.


Snippet from ''the australian'' today

''The WHO has said Tamiflu was working against strains of the new H1N1 flu but some analysts have expressed concern it might be less effective than Relenza, GlaxoSmithKline's inhaled drug, since there have been widespread reports of resistance by seasonal H1N1 flu. ''

http://www.theaustralian.news.com.au/story/0,25197,25712167-12377,00.html